ApconiX Welcomes George Buchanan

George joins ApconiX as a placement student for the month of August.  George graduated from the University of Newcastle last year after studying Biology.  He decided to take a year out before beginning a master’s degree in stem cell technology and regenerative medicine at the University of Nottingham in September.

George was keen to gain experience in real laboratories and previously worked at United Utilities and the medical device company H&T Presspart in Blackburn.  Working at Alderley Park presented an opportunity too good to miss and George was persistent in ensuring he secured the chance to join ApconiX this summer.

For the last 3 months George has been in Vellore, in the state of Tamil Nadu, southern India volunteering with the International Citizen’s Service. Education around health and social issues was a major element of the project.

George has a particular interest in stem cell research, commenting “Stem cells is an exploding field and there are huge, if not endless possibilities in many areas of medicine”.  His dissertation was on induced pluripotent stem cells and the potential in treating Parkinson’s disease.

“ApconiX are very happy to welcome George ahead of his master’s degree in stem cell technology.  We will be able to give him some sound training in cell culture and cell line profiling which will add to his fast-developing laboratory skills,” added Dr Michael Morton.

By |2018-11-28T15:31:28+00:00July 31st, 2018|Ion Channels, Careers|Comments Off on ApconiX Welcomes George Buchanan

About the Author:

Dr Michael Morton, PhD, Director and Cofounder, ApconiX, UK, an integrated toxicology and ion channel company that brings together a team of world-renowned nonclinical safety experts with over 400 years of drug discovery and development experience. Mike graduated from the University of Wolverhampton with a degree in Biomedical Sciences and then aspiration to work in hospital pathology. Having finished his Sandwich placement in Clinical Biochemistry at Sandwell Hospital and Mike subsequently gained a MSc in Clinical Biochemistry from the University of Manchester and carried out research into porphyrin metabolism. Moving to the University of Leeds, Mike completed his PhD in Pharmacology at researching adenosine receptor expression in the rat kidney . Mike was introduced to ion channels as a Post-Doc at Leeds and Yale University, patching with the likes of Fred Sigworth and Steve Hebert, then joined the Global Ion Channel Initiative at AstraZeneca. Mike worked at AstraZeneca for eight years before founding ApconiX with Professor Ruth Roberts and Dr Richard Knight. Mike has a serious passion for ion channels. And he’s very good at them . He is a serious scientist (with a serious sense of humour) who wants to make sure that every customer understands the consequences of the results he obtains and works with his colleagues to ensure a better decision is made on drug safety.